Investor Directory
Perceptive Advisors logo

Perceptive Advisors

Investment firm

Stages
Seed, Series A, Growth, Public
Based in
New York, New York
Focus
Mental & Behavioural Health, Pharma & Drug Discovery

Perceptive was founded in 1999 and manages about $11 billion across its strategies as of June 30, 2026. Its funds include the Perceptive Life Sciences Fund, the Perceptive Credit Opportunities Fund, and the Perceptive Xontogeny Venture Fund, and chief executive Joseph Edelman says the firm examines biotechnologies for efficacy and impact. Its office is at Astor Place in New York. HTS covered Perceptive leading Talkiatry's $210 million Series D, with a16z participating. Talkiatry employs more than 800 psychiatrists and runs its scheduling and back office on its own AI software.

Perceptive Advisors invests in the life sciences industry through public equity, credit, capital solutions, and venture strategies.

Notable investments

Companies in the directory

The journey

How Perceptive Advisors got here, step by step.

  1. 1999

    Founded

    Perceptive Advisors is founded to invest in life sciences.

Investors at similar stages

Related on The Signal

Your daily HealthTech Signal

No hype. Just signal.

Get the latest HealthTech news, understand why it matters, and see where the industry is headed.

5-minute read Delivered daily Unsubscribe anytime

Read by teams at companies like:

Mayo Clinic logoMayo ClinicCleveland Clinic logoCleveland ClinicJohns Hopkins logoJohns HopkinsKaiser Permanente logoKaiser PermanenteEpic logoEpicPhilips logoPhilipsMedtronic logoMedtronicGE HealthCare logoGE HealthCare